EMA Expired: Avandamet (rosiglitazone;metformin hydrochloride) — SmithKline Beecham Plc

View source ↗

Summary

Expired status for Avandamet (rosiglitazone/metformin) indicating it is no longer active in the market in the EMA record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandamet (rosiglitazone/metformin)

Snippet

Status: Expired. Therapeutic area: Diabetes Mellitus, Type 2. MAH: SmithKline Beecham Plc. Decision date: 03/12/2010